| ₹ crore | Q1 FY27 | Q1 FY26 | Change |
|---|---|---|---|
| Revenue | 21.3 | 14.9 | +43.1% |
| EBITDA | 3.1 | 1.7 | +79.4% |
| EBITDA margin | 14.4% | 11.5% | +2.9 pts |
| Profit before tax | 3.3 | 1.9 | +74.4% |
| Net profit | 2.3 | 1.4 | +72.7% |
| EPS | ₹0.63 | ₹0.35 | +80.0% |
Amounts on the left scale in ₹ crore; per cent on the right, dashed. L = lakh crore, K = thousand crore. Touch the chart to read any period.
| Tap a line for its trend | Currentlast 12M | FY26Mar 2026 | FY25Mar 2025 | FY24Mar 2024 | FY23Mar 2023 | FY22 and earlierAlpha Plus |
|---|
| 99.2 | — | — | — | — | FY22 and earlierEvery year the company has filed comes with Alpha Plus. | |
| 7.6 | 7.6 | 6.1 | 8.8 | 7.5 | ||
| 1.0 | 1.0 | 0.6 | 0.6 | 0.5 | ||
| 10.8 | 10.8 | 0.8 | 0.0 | 1.0 | ||
| 103 | — | — | — | — | ||
| 71.4 | 65.0 | 56.6 | 64.5 | 85.6 | ||
| — | +14.9% | −12.3% | −24.6% | — | ||
| 5.0 | 3.7 | 4.2 | 7.1 | 5.2 | ||
| 7.0% | 5.6% | 7.5% | 11.0% | 6.1% | ||
| 3.9 | 2.6 | 3.4 | 6.7 | 4.9 | ||
| 4.1 | 3.1 | 3.8 | 6.2 | 4.4 | ||
| 5.7% | 4.7% | 6.8% | 9.7% | 5.1% | ||
| ₹1.12 | ₹0.84 | ₹0.99 | ₹1.60 | ₹1.12 | ||
| — | −14.9% | −38.5% | +43.1% | — | ||
| — | −3.9 | 2.7 | 9.2 | 5.4 | ||
| — | −2.6 | −2.3 | −3.6 | −1.1 | ||
| −6.5 | −6.5 | 0.4 | 5.5 | 4.2 | ||
From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.
In ₹ Crore except Per Share 12 Months Ending | FY23 31/03/2023 | FY24 31/03/2024 | FY25 31/03/2025 | FY26 31/03/2026 | Current/LTM TTM · last close | |
|---|---|---|---|---|---|---|
| Market Capitalization | — | — | — | — | 99.2 | |
| - Cash, Equiv & ST Investments | 7.5 | 8.8 | 6.1 | 7.6 | 7.6 | |
| + Minority Interest | 0.5 | 0.6 | 0.6 | 1.0 | 1.0 | |
| + Total Debt | 1.0 | 0.0 | 0.8 | 10.8 | 10.8 | |
| Enterprise Value | — | — | — | — | 103.4 | |
| Revenue | 85.6 | 64.5 | 56.6 | 65.0 | 71.4 | |
| Growth %, YoY | — | -24.6 | -12.3 | +14.9 | — | |
| EBITDA | 5.2 | 7.1 | 4.2 | 3.7 | 5.0 | |
| Margin % | 6.05 | 11.00 | 7.48 | 5.62 | 7.01 | |
| EBIT | 4.9 | 6.7 | 3.4 | 2.6 | 3.9 | |
| Net Income | 4.4 | 6.2 | 3.8 | 3.1 | 4.1 | |
| Margin % | 5.09 | 9.66 | 6.77 | 4.74 | 5.69 | |
| EPS, Adj (current shares) | 1.12 | 1.60 | 0.99 | 0.84 | 1.12 | |
| Growth %, YoY | — | +43.1 | -38.5 | -14.9 | — | |
| Cash from Operations | 5.4 | 9.2 | 2.7 | -3.9 | — | |
| Capital Expenditures | -1.1 | -3.6 | -2.3 | -2.6 | — | |
| Free Cash Flow | 4.2 | 5.5 | 0.4 | -6.5 | -6.5 | |
Prices at the 29 October 2026 close · figures from the company's filings with NSE
Hindcon Chemicals (NSE: HINDCON) had a market capitalisation of ₹103 crore at the 29 October 2026 close (₹26.64 a share), a PE ratio of 23.7 on the last four quarters' profit and a price-to-book ratio of 1.80. In FY26 its consolidated net profit was ₹3.2 crore on revenue of ₹65 crore; in Q1 FY27 (April–June 2026) it was ₹2.4 crore, up 81.0% year on year. Its debt-to-equity ratio was 0.19 on 31 March 2026. Promoters held 69.02% of the shares on 30 September 2026.
Hindcon Chemicals' PE ratio is 23.7 at the 29 October 2026 close (₹26.64 a share): a market capitalisation of ₹103 crore divided by consolidated net profit of ₹4.3 crore over the last four quarters (Q2 FY26 to Q1 FY27). On FY26 net profit (₹3.2 crore) it is 31.7.
Hindcon Chemicals' debt-to-equity ratio was 0.19 on 31 March 2026: borrowings of ₹10.8 crore against total equity of ₹58.1 crore. A year earlier, on 31 March 2025, it was 0.01.
Hindcon Chemicals' net worth — shareholders' equity in its consolidated balance sheet — was ₹57.1 crore on 31 March 2026, up 5.7% from ₹54 crore a year earlier. Its market value is a different figure: a market capitalisation of ₹103 crore at the 29 October 2026 close.
Hindcon Chemicals' price-to-book (PB) ratio is 1.80 at the 29 October 2026 close: a market capitalisation of ₹103 crore divided by shareholders' equity (book value) of ₹57.1 crore on 31 March 2026. That is a book value of ₹14.82 per share against a share price of ₹26.64.
Hindcon Chemicals' book value per share was ₹14.82 on 31 March 2026: shareholders' equity of ₹57.1 crore divided by the 3.85 crore shares in issue, up 5.2% from ₹14.08 a year earlier. The share price at the 29 October 2026 close was ₹26.64.
Promoters held 69.02% of Hindcon Chemicals on 30 September 2026, up 0.21 percentage points from 68.81% the previous quarter and up 0.31 percentage points from 68.71% a year earlier, according to the shareholding pattern filed with NSE.
Hindcon Chemicals' market capitalisation was ₹103 crore at the 29 October 2026 close: 3.85 crore shares at ₹26.64 each.
No. Hindcon Chemicals had borrowings of ₹10.8 crore on 31 March 2026 (consolidated balance sheet), a debt-to-equity ratio of 0.19. Its cash and current investments were ₹18.9 crore, so it held net cash of ₹8.1 crore.
Hindcon Chemicals' basic earnings per share (EPS) were ₹0.84 in FY26, against ₹1.00 in FY25. Over the last four quarters (Q2 FY26 to Q1 FY27) they add up to ₹1.12.
In FY26, Hindcon Chemicals' return on equity (ROE) was 5.8% and its return on capital employed (ROCE) was 4.6%. ROE is net profit divided by average shareholders' equity (the start and end of the year); ROCE is operating profit (EBIT) divided by average capital employed (total assets less current liabilities). In FY25, ROE was 7.3% and ROCE 6.4%.
Hindcon Chemicals' latest results are for Q1 FY27 (April–June 2026), filed on 12 August 2026: consolidated net profit ₹2.4 crore, up 81.0% from ₹1.3 crore in Q1 FY26; revenue from operations ₹21.3 crore, up 43.1% year on year.
At the 29 October 2026 closing prices, on FY26 net profit, Hindcon Chemicals' PE ratio is 31.7, the highest of the four: Crown Lifters 13.6, The Grob Tea 17.0 and Par Drugs And Chemicals 10.8, a peer average of 13.8. Each is the company's market capitalisation at that price divided by its FY26 net profit.
On 30 September 2026, Hindcon Chemicals' shares were held by promoters 69.02% and retail and other non-institutional investors 30.98%.
In FY26, Hindcon Chemicals generated ₹3.9 crore of cash from operations and spent ₹2.6 crore on capital expenditure (property, plant, equipment and intangibles), leaving free cash flow of −₹6.5 crore. In FY25 it was ₹40 lakh.
Hindcon Chemicals will announce its Q2 FY27 results (July–September 2026) on Wednesday, 4 November 2026, the date of the board meeting it has notified to the exchanges.
In FY26 (April 2025–March 2026), Hindcon Chemicals' consolidated net profit was ₹3.2 crore, down 14.9% from ₹3.8 crore in FY25, on revenue from operations of ₹65 crore (up 14.9%). Over three years, from FY23, net profit was down 25.1%.
On FY26 consolidated figures, against Crown Lifters, The Grob Tea and Par Drugs And Chemicals: Hindcon Chemicals' operating margin of 4.1% is the third highest of the four (Crown Lifters 34.2%, The Grob Tea 2.4%, Par Drugs And Chemicals 13.0%; peer average 16.5%); its return on equity of 5.8% is the lowest of the four (Crown Lifters 12.8%, The Grob Tea 6.4%, Par Drugs And Chemicals 12.4%; peer average 10.5%); its revenue growth over three years of −8.8% a year is the lowest of the four (Crown Lifters 27.3% a year, The Grob Tea 3.8% a year, Par Drugs And Chemicals 2.7% a year; peer average 11.2% a year).
In FY26, Hindcon Chemicals earned net profit of ₹3.2 crore on revenue of ₹65 crore, against ₹8.9 crore on ₹39.7 crore for Crown Lifters. Hindcon Chemicals' operating margin was 4.1% (Crown Lifters 34.2%) and its return on equity 5.8% (Crown Lifters 12.8%). At the 29 October 2026 close, Hindcon Chemicals' market capitalisation was ₹103 crore against ₹121 crore for Crown Lifters, and its PE ratio on FY26 profit 31.7 against 13.6.
From Hindcon Chemicals' own consolidated results, balance sheets and shareholding patterns filed with NSE, and NSE prices (the latest used here: the 29 October 2026 close). Ratios are calculated by Alphave from those filings as each answer describes.
Consolidated figures from the company's filings with NSE; prices are NSE closing prices.